Compare Vaxcyte Inc. Common Stock (PCVX) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Teucrium Soybean Fund — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Teucrium Soybean Fund trades at $27.2 (market cap $43.28M). The key difference: Vaxcyte Inc. Common Stock is far larger — about 242.8× Teucrium Soybean Fund's market cap, and Teucrium Soybean Fund is more actively traded (28,719 versus 2,644,694). Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Teucrium Soybean Fund for 25 Days on average.
| PCVX | SOYB | |
|---|---|---|
Market Cap | $10.51B | $43.28M |
Volume | 2,644,694 | 28,719 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $73.82 | $28.14 |
52-Week Low | $40.32 | $21.59 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $9.14B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOYB trades at $27.33, down 0.51% today, with a bullish technical signal driven by moving averages. The stock is consolidating near key support at $27, with neutral oscillators indicating limited momentum. Recent news highlights potential catalysts from U.S.-China trade talks, which could boost soybean demand.
The outlook hinges on trade developments and commodity price trends, offering upside if diplomatic progress materializes. Risks include geopolitical tensions and commodity market volatility. Analyst sentiment appears cautiously optimistic, but fundamental data remains sparse for detailed assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
